REGISTRIES AND COHORTS TO ACCELERATE EARLY PHASE ALZHEIMER’S TRIALS. A REPORT FROM THE E.U./U.S. CLINICAL TRIALS IN ALZHEIMER’S DISEASE TASK FORCE
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The EU/US/CTAD Task Force, an international collaboration of AD investigators from industry and academia, met in Barcelona, Spain, on November 4th, 2015, to explore existing and planned patient registries and other clinical trial infrastructure meant to expedite recruitment of large numbers of participants into clinical trials and improve their productivity. The Task Force identified a number of approaches currently being tested around the world, including the use of predictive algorithms to identify individuals likely to have prodromal or preclinical AD, the establishment of clinical trial networks to streamline trials, and reforming the informed consent process to make it less burdensome to both investigators and trial participants. Multi-national systems such as the European Prevention of Alzheimer’s Dementia (EPAD) and the Global Alzheimer’s Platform (GAP) offer value for sponsors, trial sites, and patients by optimizing efforts to find effective disease-modifying and symptomatic treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
King, N. S., Crawford, S., Wenden, F. J., Moss, N. E. G., & Wade, D. T. (1995) · Journal of Neurology · doi:10.1007/bf00868811 · Cited by 1,460
Initial Reliability and Validity of the Ohio State University TBI Identification Method
Corrigan, J. D., & Bogner, J. (2007) · Journal of Head Trauma Rehabilitation · doi:10.1097/01.htr.0000300227.67748.77 · Cited by 816
Obstacles and opportunities in Alzheimer’s clinical trial recruitment
Watson, J. L., Ryan, L., Silverberg, N., Cahan, V., & Bernard, M. A. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1314 · Cited by 204
Cavedo, E., Lista, S., Khachaturian, Z., Aisen, P., Amouyel, P., Herholz, K., Jack Jr, C. R., Sperling, R., Cummings, J., Blennow, K., et al. (2014) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2014.32 · Cited by 67
Self-citation
Cited by
Alzheimer's disease drug development pipeline: 2018
Cummings, J., Lee, G., Ritter, A., & Zhong, K. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.03.009 · Cited by 697
Self-citationTowards a future where Alzheimer’s disease pathology is stopped before the onset of dementia
van der Flier, W. M., de Vugt, M. E., Smets, E. M. A., Blom, M., & Teunissen, C. E. (2023) · Nature Aging · doi:10.1038/s43587-023-00404-2 · Cited by 220
Walsh, T., Duff, L., Riviere, M. E., Tariot, P. N., Doak, K., Smith, M., Borowsky, B., Lopez Lopez, C., Arratia, P. C., Liu, F., et al. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.27 · Cited by 18
“Such prevention trials require a large outreach and screening effort to identify eligible participants (7-9).”
BackgroundSelf-citationCocroft, S., Welsh‐Bohmer, K. A., Plassman, B. L., Chanti‐Ketterl, M., Edmonds, H., Gwyther, L., McCart, M., MacDonald, H., Potter, G., & Burke, J. R. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12048 · Cited by 16
“The framework proposed by Dilworth-Anderson30,31 on the recruitment and retention of diverse groups in AD research indicates that (1) cultural sensitivity; (2) building trust relationships; (3) inclusive access to research; (4) ongoing connection with research participants; and (5) allocating resources to meet the cos…”
BackgroundMethod
Metadata
- Authors
- Aisen, P., Touchon, J., Andrieu, S., Boada, M., Doody, R., Nosheny, R. L., Langbaum, J. B., Schneider, L., Hendrix, S., Wilcock, G., Molinuevo, J. L., Ritchie, C., Ousset, P.-J., Cummings, J., Sperling, R., DeKosky, S. T., Lovestone, S., Hampel, H., Petersen, R., Legrand, V., Egan, M., Randolph, C., Salloway, S., Weiner, M., & Vellas, B.
- Venue
- The Journal of Prevention of Alzheimer's Disease
- Publisher
- Elsevier BV
- Published
- 2016
- Volume
- 3
- Issue
- 2
- Pages
- 1-7
- ISSN
- 2274-5807 (ISSN-L)
- OpenAlex
- W2571209866
- Cited by
- 51
- References
- 4
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: REGISTRIES AND COHORTS TO ACCELERATE EARLY PHASE ALZHEIMER’S TRIALS. A REPORT FROM THE E.U./U.S. CLINICAL TRIALS IN ALZHEIMER’S DISEASE TASK FORCE. https://app.cochat.ai/papers/10.14283/jpad.2016.97
- The paper
- Aisen, P., Touchon, J., Andrieu, S., Boada, M., Doody, R., Nosheny, R. L., Langbaum, J. B., Schneider, L., Hendrix, S., Wilcock, G., Molinuevo, J. L., Ritchie, C., Ousset, P.-J., Cummings, J., Sperling, R., DeKosky, S. T., Lovestone, S., Hampel, H., Petersen, R., . . . Vellas, B. (2016). REGISTRIES AND COHORTS TO ACCELERATE EARLY PHASE ALZHEIMER’S TRIALS. A REPORT FROM THE E.U./U.S. CLINICAL TRIALS IN ALZHEIMER’S DISEASE TASK FORCE. The Journal of Prevention of Alzheimer's Disease. https://doi.org/10.14283/jpad.2016.97
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.